| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.05 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.091 | 0.06 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.06 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |